Chemoinformaics analysis of 1-Methyl-2-tridecylquinolin-4-one
| Molecular Weight | 341.539 | nRot | 12 |
| Heavy Atom Molecular Weight | 306.259 | nRig | 12 |
| Exact Molecular Weight | 341.272 | nRing | 2 |
| Solubility: LogS | -6.654 | nHRing | 1 |
| Solubility: LogP | 7.612 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 35 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 63.6498 |
| nHD | 0 | BPOL | 37.6902 |
| QED | 0.41 |
| Synth | 2.126 |
| Natural Product Likeliness | 0.316 |
| NR-PPAR-gamma | 0.304 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.568 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.776 |
| MDCK | 0.0000102 |
| BBB | 0.669 |
| PPB | 0.980747 |
| VDSS | 2.357 |
| FU | 0.00628019 |
| CYP1A2-inh | 0.298 |
| CYP1A2-sub | 0.218 |
| CYP2c19-inh | 0.489 |
| CYP2c19-sub | 0.208 |
| CYP2c9-inh | 0.146 |
| CYP2c9-sub | 0.947 |
| CYP2d6-inh | 0.32 |
| CYP2d6-sub | 0.716 |
| CYP3a4-inh | 0.329 |
| CYP3a4-sub | 0.103 |
| CL | 4.387 |
| T12 | 0.048 |
| hERG | 0.206 |
| Ames | 0.674 |
| ROA | 0.087 |
| SkinSen | 0.954 |
| Carcinogencity | 0.081 |
| EI | 0.973 |
| Respiratory | 0.57 |
| NR-Aromatase | 0.133 |
| Antiviral | Yes |
| Prediction | 0.810181 |